Siegfried successfully places senior bonds of CHF 200 million

EQS  | 
aufrufe Aufrufe: 94
A-
A+
Lesemodus
playAudio
playTeilen
- pixabay.com

Siegfried AG / Key word(s): Bond Siegfried successfully places senior bonds of CHF 200 million 26.05.2026 / 14:15 CET/CEST


Media Release Zofingen, May 26, 2026

Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry, today successfully placed bonds in the amount of CHF 200 million with a 1.35% coupon. The settlement date of the bonds is June 15, 2030.

Reto Suter, Chief Financial Officer: “This transaction further strengthens Siegfried’s financial position and maintains strategic flexibility for future growth initiatives. The strong investor response reflects confidence in both our resilient business model and the long-term prospects of the CDMO market."

The bonds were placed with investors in the Swiss market under the joint lead of UBS and Zürcher Kantonalbank. Siegfried will file an application for the bonds to be admitted for listing and trading on the SIX Swiss Exchange.

Siegfried Holding AG today successfully placed senior bonds in the amount of CHF 200 million. The bonds will have a tenor of four years and a coupon of 1.35%.

Contact  
   
Financial analysts: Media:
Dr. Reto Suter Peter Stierli
Chief Financial Officer Head Corporate Communications
reto.suter@siegfried.ch peter.stierli@siegfried.ch
Tel. +41 62 746 11 35 Tel. +41 62 746 15 51
   
Siegfried Holding AG  
Untere Bruehlstrasse 4  
CH-4800 Zofingen  

About Siegfried The Siegfried Group is a global life sciences company with 16 sites in Switzerland, Germany, Spain, France, Malta, the USA, Australia and China. In 2025, the company achieved sales of CHF 1,327.8 million and employed on 31.12.2025 more than 3,800 people. Siegfried Holding AG is publicly listed on the SIX Swiss Exchange (SIX: SFZN). 

Siegfried is active in manufacturing pharmaceutical APIs (and their intermediates) as well as drug products (tablets, capsules, sterile vials, ampoules, cartridges and ointments) for the pharmaceutical industry and provides development services. Cautionary statements regarding forward-looking statements This media release includes statements concerning the future. They are based on assumptions and expectations that may prove to be wrong. They should be considered with due caution as, by definition, they contain known and unknown risks, insecurities and other factors which could result in a difference in the actual results, financial situation, developments or the success of Siegfried Holding AG or Siegfried Group from the explicit or implicit assumptions made in these statements.

expect more  

Siegfried AG Untere Brühlstrasse 4 4800 Zofingen, Switzerland +41 62 746 11 11 info@siegfried.ch www.siegfried.ch  


End of Media Release View original content: EQS News


Language: English
Company: Siegfried AG
Untere Brühlstrasse 4
4800 Zofingen
Switzerland
Phone: +41 62 746 11 11
E-mail: info@siegfried.ch
Internet: https://www.siegfried.ch
ISIN: CH1429326825
Listed: SIX Swiss Exchange
EQS News ID: 2333634
 
End of News EQS News Service

2333634  26.05.2026 CET/CEST


Werte aus dem Artikel:
Siegfried Aktie 78,35 CHF -1,07%

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.

Themen im Trend